Factors such as cost, access, and lack of long-term safety data may influence how P-CABs are integrated into practice.
Currently, coxib therapy is more expensive than combination therapy using a nonselective NSAID plus a PPI. Conclusions: Compared with combination therapy including a nonselective NSAID and PPI ...
The authors conclude that gastric acid suppression induced by PPIs, but not by H 2 RAs, is associated with an increased risk of salmonella and campylobacter enteric infections. They suggest that ...
As acupuncture has shown considerable benefits in patients with various gastrointestinal disorders, Dickman and colleagues compared this alternative therapy with doubling the dose of the PPI in ...
The following is a summary of “Accelerated risk of renal disease progression in pre-ESRD patients with proton pump inhibitors use: a nationwide population-based study,” published in the December 2024 ...